High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma
Abstract T-cell lymphoma (TCL) is an aggressive and genetically heterogeneous malignancy with adverse clinical outcomes; thus, it is worth exploring biomarkers for risk stratification. Previous studies have demonstrated that transmembrane protein 244 gene (TMEM244) is ectopically expressed in Sézary...
| Published in: | Biomarker Research |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-07-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40364-022-00395-z |
